Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Prostate. 2010 Sep 21;71(4):394–402. doi: 10.1002/pros.21253

Table 2.

Comparison of the Frequencies of the Risk alleles (Single Nucleotide Polymorphisms) in Prostate Cancer Cases with a “Normal” PSA and DRE and Healthy Volunteer Controls

SNP Chrom.
Location
Allele Percent of P Value OR
(95% CI)
Best-Fit
Genetic
Model
Cases Controls
rs721048 2p15 A 18.5 16.7 0.40 1.1 (0.8-1.5) Recessive
rs10934853 3q21 A 31.8 27.1 0.07 1.3 (.10-1.6) Dominant
rs2736098 5p15 A 31.8 26.0 0.029 1.3 (1.0-1.7) Recessive
rs401681 5p15 C 57.1 54.0 0.27 1.1 (0.9-1.4) Dominant
rs16901979 8q24 A 5.9 4.0 0.13 1.5 (0.9-2.5) Dominant
rs16902094 8q24 G 15.3 13.8 0.46 1.1 (0.8-1.5) Dominant
rs445114 8q24 T 63.6 63.3 0.95 1.0 (0.8-1.3) Dominant
rs6983267 8q24 G 59.4 50.5 0.002 1.4 (1.1-1.8) Dominant
rs1447295 8q24 A 14.3 8.6 0.002 1.8 (1.3-2.5) Dominant
rs10993994 10q11 T 48.8 39.3 0.0009 1.5 (1.2-1.8) Recessive
rs11228565 11q13 A 25.6 19.4 0.009 1.4 (1.1-1.9) Dominant
rs10896450 11q13 G 57.6 49.5 0.005 1.4 (1.1-1.7) Dominant
rs11649743 17q12 G 83.7 82.5 0.60 1.1 (0.8-1.5) Recessive
rs4430796 17q12 A 54.7 51.6 0.28 1.1 (0.9-1.4) Dominant
rs1859962 17q24 G 53.2 49.0 0.15 1.2 (0.9-1.5) Recessive
rs8102476 19q13 C 60.6 57.8 0.32 1.1 (0.9-1.4) Dominant
rs5945572 Xp11 A 42.4 37.3 0.21 1.2 (0.9-1.7) Dominant